Susquehanna Fundamental Investments’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Susquehanna Fundamental Investments’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,141	Closed	-$439K	–	1671
2020 Q4	$439K	Buy	25,141 +2,674	+12%	+$37.5K	0.01%	1151
2020 Q3	$263K	Buy	22,467 +4,139	+23%	+$54.9K	0.01%	1107
2020 Q2	$238K	Buy	+18,328	New	+$220K	0.01%	808

Susquehanna Fundamental Investments's OXFD Position: Q1 2021 in Review

Susquehanna Fundamental Investments sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 25,141 shares — an estimated $439K sold.

Susquehanna Fundamental Investments first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $439K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Susquehanna Fundamental Investments reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 25,141 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $439K.
Susquehanna Fundamental Investments first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
Susquehanna Fundamental Investments's Oxford Immunotec Global PLC Ordinary Shares position peaked at $439K in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2021, filed 17 May 2021.